Our allogeneic platform offers broader and faster treatment with cell therapies where speed and cost are paramount for patient access and where our proprietary potent cell format offers sufficient persistence.
Treatment Speed
Faster from diagnosis to treatment
Starting material from healthy donors
Cost
Simpler manufacturing process
1 batch ~ 1000 patients
Access
Off-the-shelf
Large treatment stock
